How a healthy balanced equine joint becomes dysfunctional and
the ideal treatment

Content on this page requires a newer version of Adobe Flash Player.

Get Adobe Flash player

 

Content on this page requires a newer version of Adobe Flash Player.

Get Adobe Flash player

 

Content on this page requires a newer version of Adobe Flash Player.

Get Adobe Flash player

*Haugland ML, Collier M, DeBault LE, et al, H-PSGAG concentration in the synovial fluid of the equine antebrachiocarpal, metacarpophalangeal, coronopedal and tibiotarsal joints following a 500 mg IM injection. The Journal of Equine Vet Science; 15(6), 1995.
**Burba D, Collier M, DeBault LE, et al, In Vivo Kinetic study on uptake and distribution of intrmuscular tritium-labeled Polysulfated Glycosaminoglycan in equine body fluid compartments and articular cartilage in an osteohealth defect model. The Journal of Equine Vet Science; 13(12), 1993.

 

Equine Therapy - Luitpold Animal Health Adequan IM Adequan IA Equiphen Paste Adequan Canine
 
 
image
logo
 

Proof that Adequan® i.m. (Polysulfated glycosaminoglycan) stimulates cartilage repair and reverses traumatic joint dysfunction

2 hours
After intramuscular injection, therapeutic levels peak in knee and hock joints.*

Within 48 hours
The hyaluronic acid (HA) in the synovial fluid nearly doubles after a single injection.* Recommended dose: 5 mL every 4 days for 7 treatments intramuscularly.**

4 days
After a single intramuscular injection, this potent enzyme inhibitor is still detected in cartilage and subchondral bone.**

For more information or to place an order call 1-800-387-6325.

Link to U.S. site Adequan.com


Product Insert     |     Privacy Policy     |     Terms & Conditions
© 2011 Novartis Animal Health Canada Inc. ® Registered trademarks of Luitpold Pharmaceuticals, Inc.; used under license.